FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 266 of 266

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TYRA Nasdaq Tyra Biosciences, Inc. 2830
UPB Nasdaq Upstream Bio, Inc. 2830
VALN Nasdaq Valneva SE 2830
VCEL Nasdaq Vericel Corporation 2830
VERA Nasdaq Vera Therapeutics, Inc. 2830
VIR Nasdaq Vir Biotechnology, Inc. 2830
VSTM Nasdaq Verastem, Inc. 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTVT Nasdaq vTv Therapeutics Inc. 2830
WUXAY Over the counter WuXi AppTec Co., Ltd. 2830
XBIT Nasdaq XBiotech Inc. 2830
XNCR Nasdaq Xencor, Inc. 2830
YCBD NYSE American cbdMD, Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 266 of 266